Skip to content

Clinical trials

Musculoskeletal Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Country / region: United Kingdom Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20122
20131
20142
20153
20163
20174
20184
20198
20205
20214
20227
20234
20247
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting11
Recruiting10
Unknown status7
Terminated6
Enrolling by invitation4
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
QED Therapeutics, a BridgeBio company8
BioMarin Pharmaceutical7
Amgen2
Calcilytix Therapeutics, Inc., a BridgeBio company2
Catabasis Pharmaceuticals2
PTC Therapeutics2
Queen Mary University of London2
Smith & Nephew Orthopaedics AG2
The Leeds Teaching Hospitals NHS Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases69
Genetic Diseases, Inborn19
Bone Diseases17
Arthritis15
Joint Diseases14
Dwarfism13
Osteochondrodysplasias13
Muscular Diseases12
Achondroplasia11
Neuromuscular Diseases11

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.